People

Jérôme Van Biervliet

Jérôme Van Biervliet

Jérôme Van Biervliet is publicly identified by VIB as Managing Director; Directors’ Committee Member; Managing Director. Leads translation and innovation as co-managing director, with a legal daily-management appointment since April 2020. His published work concerns translating academic research into biotechnology companies and industrial partnerships. Institutional investments are separate from unverified personal checks.

Roles

VIB (Flanders Institute for Biotechnology)

Directors’ Committee Member; Managing Director

Current
Augustine Therapeutics

Interim Management (2019 company launch; historical)

Current